Correlation Between Aramark Holdings and Canopus BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aramark Holdings and Canopus BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aramark Holdings and Canopus BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aramark Holdings and Canopus BioPharma Incorporated, you can compare the effects of market volatilities on Aramark Holdings and Canopus BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aramark Holdings with a short position of Canopus BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aramark Holdings and Canopus BioPharma.

Diversification Opportunities for Aramark Holdings and Canopus BioPharma

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Aramark and Canopus is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Aramark Holdings and Canopus BioPharma Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canopus BioPharma and Aramark Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aramark Holdings are associated (or correlated) with Canopus BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canopus BioPharma has no effect on the direction of Aramark Holdings i.e., Aramark Holdings and Canopus BioPharma go up and down completely randomly.

Pair Corralation between Aramark Holdings and Canopus BioPharma

Given the investment horizon of 90 days Aramark Holdings is expected to under-perform the Canopus BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Aramark Holdings is 25.19 times less risky than Canopus BioPharma. The stock trades about -0.07 of its potential returns per unit of risk. The Canopus BioPharma Incorporated is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Canopus BioPharma Incorporated on October 30, 2024 and sell it today you would earn a total of  0.00  from holding Canopus BioPharma Incorporated or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy97.44%
ValuesDaily Returns

Aramark Holdings  vs.  Canopus BioPharma Incorporated

 Performance 
       Timeline  
Aramark Holdings 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aramark Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent primary indicators, Aramark Holdings is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.
Canopus BioPharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Canopus BioPharma Incorporated are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward indicators, Canopus BioPharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Aramark Holdings and Canopus BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aramark Holdings and Canopus BioPharma

The main advantage of trading using opposite Aramark Holdings and Canopus BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aramark Holdings position performs unexpectedly, Canopus BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canopus BioPharma will offset losses from the drop in Canopus BioPharma's long position.
The idea behind Aramark Holdings and Canopus BioPharma Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk